Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Efficient designs for studying synergistic drug combinations

R J Tallarida1, D J Stone, R B Raffa

  • 1Department of Pharmacology, School of Medicine, Temple University, Philadelphia, PA 19140-5104, USA.

Life Sciences
|January 1, 1997
PubMed
Summary

This study introduces a novel method for analyzing drug combinations, simplifying the process of identifying synergistic effects. The composite additive dose-effect relation offers a more efficient alternative to traditional isobolographic analysis for drug interaction studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Galcanezumab: a humanized monoclonal antibody for the prevention of migraine and cluster headache.

Drugs of today (Barcelona, Spain : 1998)·2020
Same author

Indirect-acting strategy of opioid action instead of direct receptor activation: dual-acting enkephalinase inhibitors (DENKIs).

Journal of clinical pharmacy and therapeutics·2018
Same author

Curcumin in turmeric: Basic and clinical evidence for a potential role in analgesia.

Journal of clinical pharmacy and therapeutics·2018
Same author

The role and mechanism of action of menthol in topical analgesic products.

Journal of clinical pharmacy and therapeutics·2018
Same author

Nature's first "atypical opioids": Kratom and mitragynines.

Journal of clinical pharmacy and therapeutics·2018
Same author

The rapid-onset antidepressant effect of ketamine: More surprises?

Journal of clinical pharmacy and therapeutics·2017

Area of Science:

  • Pharmacology
  • Drug Interaction Analysis
  • Statistical Modeling

Background:

  • Distinguishing between additive and synergistic drug combinations is crucial for effective pharmacotherapy.
  • Traditional methods, such as isobolographic analysis, often require extensive animal use and experimenter time.
  • There is a need for more efficient and less resource-intensive methods for drug combination analysis.

Purpose of the Study:

  • To develop and validate a novel composite additive dose-effect relation method for analyzing drug combinations.
  • To compare the efficacy of this new method with traditional isobolographic analysis.
  • To assess the potential for reducing experimental resource requirements in drug interaction studies.

Main Methods:

  • Individual drug dose-effect data were used to generate theoretically additive total dose combinations.

Related Experiment Videos

  • A composite additive dose-effect relation was constructed for a fixed drug proportion.
  • This composite relation was compared with the actual dose-effect relation of a drug mixture (morphine and clonidine) at the same proportion.
  • The results were compared with those obtained from isobolographic analysis.

    • Main Results:

    • The composite additive dose-effect relation approach yielded results virtually identical to isobolographic analysis for the morphine and clonidine combination.
    • Both methods demonstrated significant synergism for this drug combination.
    • Neither method required constraining drug regression lines to parallelism.
    • The composite method allowed observation of drug interactions over a range of effects.

    Conclusions:

    • The composite additive dose-effect relation is a valid and efficient alternative to isobolographic analysis for determining drug synergism.
    • This novel approach reduces the size of data sets needed for analysis.
    • It offers a more comprehensive understanding of drug interactions across various effect levels.